Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release: SPARC Licenses Development and Commercialization Rights of PDP-716 and SDN-037 to Visiox Pharma
08-12-2021
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release: "SPARC enters into a licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target."
03-12-2021
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release: SPARC to Provide Update on Clinical Programs and R&D Pipeline.
26-11-2021
Bigul

Sun Pharma Advanced Research Company Ltd - 532872 - Board Meeting Intimation for Consideration Of Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2021

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2021 ,inter alia, to consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2021
23-10-2021
Next Page
Close

Let's Open Free Demat Account